SEC Comment Letter 0000000000-24-011766 to BIO-PATH HOLDINGS, INC. (BPTH)
BIO-PATH HOLDINGS, INC.
Date: Oct. 21, 2024 · CIK: 0001133818 · Accession: 0000000000-24-011766
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-282702
Letter
October 21, 2024 Peter H. Nielsen President and Chief Executive Officer Bio-Path Holdings, Inc. 4710 Bellaire Boulevard, Suite 210 Bellaire, TX 77401 Re:Bio-Path Holdings, Inc. Registration Statement on Form S-3 Filed October 17, 2024 File No. 333-282702 Dear Peter H. Nielsen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:William R. Rohrlich, II, Esq.
Show Raw Text
October 21, 2024
Peter H. Nielsen
President and Chief Executive Officer
Bio-Path Holdings, Inc.
4710 Bellaire Boulevard, Suite 210
Bellaire, TX 77401
Re:Bio-Path Holdings, Inc.
Registration Statement on Form S-3
Filed October 17, 2024
File No. 333-282702
Dear Peter H. Nielsen:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:William R. Rohrlich, II, Esq.